Ting-Ting Yin, Yan Bi, Ping Li, Shan-Mei Shen, Xiao-Lu Xiong, Li-Jun Gao, Can Jiang, Yan Wang, Wen-Huan Feng, Da-Long Zhu. Diabetes Ther 2018
Times Cited: 12
Times Cited: 12
Times Cited
Times Co-cited
Similarity
A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin.
Hiroshi Nomoto, Hideaki Miyoshi, Hajime Sugawara, Kota Ono, Shingo Yanagiya, Mayuko Oita, Akinobu Nakamura, Tatsuya Atsumi. Diabetol Metab Syndr 2017
Hiroshi Nomoto, Hideaki Miyoshi, Hajime Sugawara, Kota Ono, Shingo Yanagiya, Mayuko Oita, Akinobu Nakamura, Tatsuya Atsumi. Diabetol Metab Syndr 2017
50
Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk.
. Diabetes Care 2016
. Diabetes Care 2016
50
International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
41
Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
33
Exenatide improves glycemic variability assessed by continuous glucose monitoring in subjects with type 2 diabetes.
Concetta Irace, Raffaella Fiorentino, Claudio Carallo, Faustina Scavelli, Agostino Gnasso. Diabetes Technol Ther 2011
Concetta Irace, Raffaella Fiorentino, Claudio Carallo, Faustina Scavelli, Agostino Gnasso. Diabetes Technol Ther 2011
33
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
33
Glycemic variability in the development of cardiovascular complications in diabetes.
Annunziata Nusca, Dario Tuccinardi, Marzia Albano, Camilla Cavallaro, Elisabetta Ricottini, Silvia Manfrini, Paolo Pozzilli, Germano Di Sciascio. Diabetes Metab Res Rev 2018
Annunziata Nusca, Dario Tuccinardi, Marzia Albano, Camilla Cavallaro, Elisabetta Ricottini, Silvia Manfrini, Paolo Pozzilli, Germano Di Sciascio. Diabetes Metab Res Rev 2018
33
Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma. Cardiovasc Diabetol 2011
Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma. Cardiovasc Diabetol 2011
25
A comparative study of the effects of a dipeptidyl peptidase-IV inhibitor and sulfonylurea on glucose variability in patients with type 2 diabetes with inadequate glycemic control on metformin.
Hun-Sung Kim, Jeong-Ah Shin, Seung-Hwan Lee, Eun-Sook Kim, Jae-Hyoung Cho, Ho-Young Son, Kun-Ho Yoon. Diabetes Technol Ther 2013
Hun-Sung Kim, Jeong-Ah Shin, Seung-Hwan Lee, Eun-Sook Kim, Jae-Hyoung Cho, Ho-Young Son, Kun-Ho Yoon. Diabetes Technol Ther 2013
25
Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.
Alessandra Di Flaviani, Fabiana Picconi, Paola Di Stefano, Ilaria Giordani, Ilaria Malandrucco, Paola Maggio, Paola Palazzo, Fabrizio Sgreccia, Carlo Peraldo, Fabrizio Farina,[...]. Diabetes Care 2011
Alessandra Di Flaviani, Fabiana Picconi, Paola Di Stefano, Ilaria Giordani, Ilaria Malandrucco, Paola Maggio, Paola Palazzo, Fabrizio Sgreccia, Carlo Peraldo, Fabrizio Farina,[...]. Diabetes Care 2011
25
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
25
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
25
Biphasic insulin aspart-30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once-daily insulin regimens using continuous glucose monitoring.
Daisuke Tsujino, Rimei Nishimura, Yoshiko Onda, Chiaki Seo, Kiyotaka Ando, Kazunori Utsunomiya. J Diabetes Investig 2017
Daisuke Tsujino, Rimei Nishimura, Yoshiko Onda, Chiaki Seo, Kiyotaka Ando, Kazunori Utsunomiya. J Diabetes Investig 2017
100
Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine.
Anthony L McCall, Daniel J Cox, Robert Brodows, John Crean, Don Johns, Boris Kovatchev. Diabetes Technol Ther 2009
Anthony L McCall, Daniel J Cox, Robert Brodows, John Crean, Don Johns, Boris Kovatchev. Diabetes Technol Ther 2009
25
Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial.
Juan P Frías, Samer Nakhle, James A Ruggles, Sergey Zhuplatov, Eric Klein, Rong Zhou, Poul Strange. Diabetes Obes Metab 2017
Juan P Frías, Samer Nakhle, James A Ruggles, Sergey Zhuplatov, Eric Klein, Rong Zhou, Poul Strange. Diabetes Obes Metab 2017
25
Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
25
Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm.
Peter A Baghurst. Diabetes Technol Ther 2011
Peter A Baghurst. Diabetes Technol Ther 2011
16
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
16
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
16
Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes.
Kozo Okada, Kiyoshi Hibi, Masaomi Gohbara, Shunsuke Kataoka, Keiko Takano, Eiichi Akiyama, Yasushi Matsuzawa, Kenichiro Saka, Nobuhiko Maejima, Mitsuaki Endo,[...]. Cardiovasc Diabetol 2015
Kozo Okada, Kiyoshi Hibi, Masaomi Gohbara, Shunsuke Kataoka, Keiko Takano, Eiichi Akiyama, Yasushi Matsuzawa, Kenichiro Saka, Nobuhiko Maejima, Mitsuaki Endo,[...]. Cardiovasc Diabetol 2015
16
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
16
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson,[...]. Circulation 2017
Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson,[...]. Circulation 2017
16
Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations.
Raffaele Marfella, Michelangela Barbieri, Rodolfo Grella, Maria Rosaria Rizzo, Giovanni Francesco Nicoletti, Giuseppe Paolisso. J Diabetes Complications 2010
Raffaele Marfella, Michelangela Barbieri, Rodolfo Grella, Maria Rosaria Rizzo, Giovanni Francesco Nicoletti, Giuseppe Paolisso. J Diabetes Complications 2010
16
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
16
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.
Lisa Quagliaro, Ludovica Piconi, Roberta Assaloni, Lucia Martinelli, Enrico Motz, Antonio Ceriello. Diabetes 2003
Lisa Quagliaro, Ludovica Piconi, Roberta Assaloni, Lucia Martinelli, Enrico Motz, Antonio Ceriello. Diabetes 2003
16
Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture.
A Risso, F Mercuri, L Quagliaro, G Damante, A Ceriello. Am J Physiol Endocrinol Metab 2001
A Risso, F Mercuri, L Quagliaro, G Damante, A Ceriello. Am J Physiol Endocrinol Metab 2001
16
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Bernard Zinman, Steven P Marso, Neil R Poulter, Scott S Emerson, Thomas R Pieber, Richard E Pratley, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Ann Marie Ocampo Francisco,[...]. Diabetologia 2018
Bernard Zinman, Steven P Marso, Neil R Poulter, Scott S Emerson, Thomas R Pieber, Richard E Pratley, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Ann Marie Ocampo Francisco,[...]. Diabetologia 2018
16
Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition.
Maria Rosaria Rizzo, Michelangela Barbieri, Raffaele Marfella, Giuseppe Paolisso. Diabetes Care 2012
Maria Rosaria Rizzo, Michelangela Barbieri, Raffaele Marfella, Giuseppe Paolisso. Diabetes Care 2012
16
Glucose variability: An emerging target for the treatment of diabetes mellitus.
Simona Frontoni, Paolo Di Bartolo, Angelo Avogaro, Emanuele Bosi, Giuseppe Paolisso, Antonio Ceriello. Diabetes Res Clin Pract 2013
Simona Frontoni, Paolo Di Bartolo, Angelo Avogaro, Emanuele Bosi, Giuseppe Paolisso, Antonio Ceriello. Diabetes Res Clin Pract 2013
16
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
16
Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction.
Gong Su, Shu-hua Mi, Hong Tao, Zhao Li, Hong-Xia Yang, Hong Zheng, Yun Zhou, Lei Tian. Diabetes Care 2013
Gong Su, Shu-hua Mi, Hong Tao, Zhao Li, Hong-Xia Yang, Hong Zheng, Yun Zhou, Lei Tian. Diabetes Care 2013
16
Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.
Boris P Kovatchev. Nat Rev Endocrinol 2017
Boris P Kovatchev. Nat Rev Endocrinol 2017
16
Comparison of tofogliflozin 20 mg and ipragliflozin 50 mg used together with insulin glargine 300 U/mL using continuous glucose monitoring (CGM): A randomized crossover study.
Soichi Takeishi, Hiroki Tsuboi, Shodo Takekoshi. Endocr J 2017
Soichi Takeishi, Hiroki Tsuboi, Shodo Takekoshi. Endocr J 2017
18
Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study).
Harpreet S Bajaj, Karri Venn, Chenglin Ye, Avril Patrick, Shivani Kalra, Hasnain Khandwala, Nadeem Aslam, David Twum-Barima, Ronnie Aronson. Diabetes Care 2017
Harpreet S Bajaj, Karri Venn, Chenglin Ye, Avril Patrick, Shivani Kalra, Hasnain Khandwala, Nadeem Aslam, David Twum-Barima, Ronnie Aronson. Diabetes Care 2017
16
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.
G B Bolli, M Songini, M Trovati, S Del Prato, G Ghirlanda, R Cordera, R Trevisan, G Riccardi, C Noacco. Nutr Metab Cardiovasc Dis 2009
G B Bolli, M Songini, M Trovati, S Del Prato, G Ghirlanda, R Cordera, R Trevisan, G Riccardi, C Noacco. Nutr Metab Cardiovasc Dis 2009
16
Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
B Guerci, L Monnier, P Serusclat, C Petit, P Valensi, D Huet, D Raccah, C Colette, S Quéré, S Dejager. Diabetes Metab 2012
B Guerci, L Monnier, P Serusclat, C Petit, P Valensi, D Huet, D Raccah, C Colette, S Quéré, S Dejager. Diabetes Metab 2012
16
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
16
Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes.
Yan Bi, Bing Zhang, Wen Xu, Huijie Yang, Wenhuan Feng, Cuiliu Li, Guoyu Tong, Ming Li, Xin Wang, Shanmei Shen,[...]. Acta Diabetol 2014
Yan Bi, Bing Zhang, Wen Xu, Huijie Yang, Wenhuan Feng, Cuiliu Li, Guoyu Tong, Ming Li, Xin Wang, Shanmei Shen,[...]. Acta Diabetol 2014
16
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.
Padma Sathyanarayana, Medhavi Jogi, Raja Muthupillai, Ramkumar Krishnamurthy, Susan L Samson, Mandeep Bajaj. Obesity (Silver Spring) 2011
Padma Sathyanarayana, Medhavi Jogi, Raja Muthupillai, Ramkumar Krishnamurthy, Susan L Samson, Mandeep Bajaj. Obesity (Silver Spring) 2011
16
Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis.
Conrad Eng, Caroline K Kramer, Bernard Zinman, Ravi Retnakaran. Lancet 2014
Conrad Eng, Caroline K Kramer, Bernard Zinman, Ravi Retnakaran. Lancet 2014
16
Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.
Daniel J Cuthbertson, Andrew Irwin, Chris J Gardner, Christina Daousi, Tej Purewal, Niall Furlong, Niru Goenka, E Louise Thomas, Valerie L Adams, Sudeep P Pushpakom,[...]. PLoS One 2012
Daniel J Cuthbertson, Andrew Irwin, Chris J Gardner, Christina Daousi, Tej Purewal, Niall Furlong, Niru Goenka, E Louise Thomas, Valerie L Adams, Sudeep P Pushpakom,[...]. PLoS One 2012
16
Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
David Russell-Jones, Rehman Khan. Diabetes Obes Metab 2007
David Russell-Jones, Rehman Khan. Diabetes Obes Metab 2007
16
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
16
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.
Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Vivian A Fonseca,[...]. Endocr Pract 2017
Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Vivian A Fonseca,[...]. Endocr Pract 2017
16
Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.
John M Lachin, Saul Genuth, David M Nathan, Bernard Zinman, Brandy N Rutledge. Diabetes 2008
John M Lachin, Saul Genuth, David M Nathan, Bernard Zinman, Brandy N Rutledge. Diabetes 2008
16
Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes.
Xingran Cui, Amir Abduljalil, Brad D Manor, Chung-Kang Peng, Vera Novak. PLoS One 2014
Xingran Cui, Amir Abduljalil, Brad D Manor, Chung-Kang Peng, Vera Novak. PLoS One 2014
16
Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?
Yoshifumi Saisho. Int J Mol Sci 2014
Yoshifumi Saisho. Int J Mol Sci 2014
16
Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
C R L Cardoso, N C Leite, C B M Moram, G F Salles. Cardiovasc Diabetol 2018
C R L Cardoso, N C Leite, C B M Moram, G F Salles. Cardiovasc Diabetol 2018
16
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.